The issue of&nbsp;the deaths of Gambian children blamed on some Indian cough syrups is still in the churn, and the World Health Organization (WHO) has said that it stands by its action of issuing an alert regarding the said medicine.&nbsp;The WHO statement&nbsp;comes after India notified it that samples obtained from the Indian pharmaceutical business Maiden Pharma, whose goods were implicated in the deaths of children in the Gambia, had been deemed to meet the necessary specifications.

Watch&nbsp;|&nbsp;<a href="https://www.wionews.com/videos/gambia-cough-syrup-deaths-after-whos-alert-indian-govts-crackdown-on-maiden-pharma-524790">Gambia cough syrup deaths: After WHO's alert, Indian govt's crackdown on Maiden Pharma</a>

<iframe allowfullscreen="" autoplay="1" frameborder="0" height="350" src="https://www.wionews.com/videos/gambia-cough-syrup-deaths-after-whos-alert-indian-govts-crackdown-on-maiden-pharma-524790/embed" width="560"></iframe>

In a letter to the global health authority dated December 13, India's drugs controller general, VG Somani, said that tests conducted on samples of Maiden Pharma's products "have been found to be complying with specifications". The letter also said that samples were not contaminated with ethylene glycol and diethylene glycol as alleged.

Talking to BBC via email, the health agency said, "WHO's mandate is to issue global alerts about potential risks. WHO stands by the action taken," adding that "contaminated syrups are dangerous and should not be in any medicine, ever".

Also read |&nbsp;<a href="https://www.wionews.com/india-news/who-drew-premature-link-between-gambia-deaths-and-india-made-cough-syrups-543653">WHO drew 'premature link' between Gambia deaths and India-made cough syrups</a>

WHO in October said that its investigators had found "unacceptable" levels of the two chemicals in Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup; cough syrups made by Maiden Pharmaceuticals, an Indian company.&nbsp;

These chemicals have been known to be toxic and can cause kidney damage.

Also read |&nbsp;<a href="https://www.wionews.com/india-news/india-committee-to-who-information-on-killer-cough-syrups-inadequate-525793">India committee tells WHO: Information on 'killer' cough syrups 'inadequate'</a>

In the letter addressed to WHO's director of regulation and prequalification Roderigo Gaspar, Somani claimed that the health agency's October statement connecting the deaths to the cough syrup made in India had done "irreparable damage" to the nation's pharmaceutical supply chain.

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The issue of the deaths of Gambian children blamed on some Indian cough syrups is still in the churn, and the World Health Organization (WHO) has said that it stands by its action of issuing an alert regarding the said medicine.

The issue of the deaths of Gambian children blamed on some Indian cough syrups is still in the churn, and the World Health Organization (WHO) has said that it stands by its action of issuing an alert regarding the said medicine. The WHO statement comes after India notified it that samples obtained from the Indian pharmaceutical business Maiden Pharma, whose goods were implicated in the deaths of children in the Gambia, had been deemed to meet the necessary specifications. Watch | Gambia cough syrup deaths: After WHO's alert, Indian govt's crackdown on Maiden Pharma In a letter to the global health authority dated December 13, India's drugs controller general, VG Somani, said that tests conducted on samples of Maiden Pharma's products "have been found to be complying with specifications". The letter also said that samples were not contaminated with ethylene glycol and diethylene glycol as alleged. Talking to BBC via email, the health agency said, "WHO's mandate is to issue global alerts about potential risks. WHO stands by the action taken," adding that "contaminated syrups are dangerous and should not be in any medicine, ever". Also read | WHO drew 'premature link' between Gambia deaths and India-made cough syrups WHO in October said that its investigators had found "unacceptable" levels of the two chemicals in Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup; cough syrups made by Maiden Pharmaceuticals, an Indian company. These chemicals have been known to be toxic and can cause kidney damage. Also read | India committee tells WHO: Information on 'killer' cough syrups 'inadequate' In the letter addressed to WHO's director of regulation and prequalification Roderigo Gaspar, Somani claimed that the health agency's October statement connecting the deaths to the cough syrup made in India had done "irreparable damage" to the nation's pharmaceutical supply chain. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Gambia deaths: WHO stands by its action of issuing alert regarding the Indian cough medicine

China is facing a very tough time as it dismantles its rigid "zero-COVID" policy and allows people to live with the virus, posing challenges preparing hospitals and ensuring people are sufficiently protected, the World Health Organisation (WHO) said.

China faces 'tough' Zero-Covid exit, says WHO

As the third anniversary of the Covid-19 pandemic approaches, the World Health Organization (WHO) on Wednesday said that it hoped that the virus would no longer be a public health emergency next year.

WHO chief Tedros Adhanom Ghebreyesus said "we have come a long way", and the death toll from Covid is now a fifth of what it was a year ago. However, he added that even that is too much.

"Last week, less than 10,000 people lost their lives. That's still 10,000 too many and there is still a lot that all countries can do to save lives," he said, adding, "we are hopeful that at some point next year, we will be able to say that Covid-19 is no longer a global health emergency."

Watch |&nbsp;China Covid: Xi administration gradually dismantles Zero-Covid policy

<iframe allowfullscreen="" autoplay="1" frameborder="0" height="350" src="https://www.wionews.com/videos/china-covid-xi-administration-gradually-dismantles-zero-covid-policy-541962/embed" width="560"></iframe>

As per AFP Tedros said that as the world looks to living with <a href="https://www.wionews.com/topics/coronavirus">Covid</a> and as nations look to learn to manage it alongside other respiratory illnesses, it is important to know more about the coronavirus's origins and understand how the pandemic began.

"We continue to call on China to share the data and conduct the studies that we have requested, to better understand the origins of this virus," said Tedros.

Also read |&nbsp;<a href="https://www.wionews.com/world/china-says-impossible-to-accurately-grasp-the-actual-number-of-covid-infected-people-542857">China says impossible to 'accurately grasp' the actual number of Covid infected people</a>

The first cases of this deadly virus were identified in the Chinese city of Wuhan. As per Tedros "all hypotheses remain on the table" including the one that alleges that the virus may have escaped from Wuhan's virology laboratories.

A meeting of the WHO emergency committee that advises Tedros on whether a virus constitutes a public health emergency of international concern (PHEIC) will discuss the criteria for ending the coronavirus emergency phase.

Also read |&nbsp;<a href="https://www.wionews.com/world/as-china-focuses-on-economic-stability-in-2023-traditional-medicine-expert-endorses-changing-covids-name-540754">In view of mutations, Covid should be renamed, says Chinese medicine expert</a>

The WHO <a href="https://www.wionews.com/topics/coronavirus">COVID-19</a>&nbsp; technical lead, Maria Van Kerkhove said that while waves of infection are still expected "it is not what it was in the beginning". The upcoming January committee meeting will look at COVID-19 and its subvariants along with their epidemiology.

As per Van Kerkhove now the deaths are mainly among unvaccinated people or those who are missing a full course of the life-saving vaccines.

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

As the third anniversary of the Covid-19 pandemic approaches, the World Health Organization (WHO) on Wednesday said that it hoped that the virus would no longer be a public health emergency next year.

As the third anniversary of the Covid-19 pandemic approaches, the World Health Organization (WHO) on Wednesday said that it hoped that the virus would no longer be a public health emergency next year. WHO chief Tedros Adhanom Ghebreyesus said "we have come a long way", and the death toll from Covid is now a fifth of what it was a year ago. However, he added that even that is too much. "Last week, less than 10,000 people lost their lives. That's still 10,000 too many and there is still a lot that all countries can do to save lives," he said, adding, "we are hopeful that at some point next year, we will be able to say that Covid-19 is no longer a global health emergency." Watch | China Covid: Xi administration gradually dismantles Zero-Covid policy As per AFP Tedros said that as the world looks to living with Covid and as nations look to learn to manage it alongside other respiratory illnesses, it is important to know more about the coronavirus's origins and understand how the pandemic began. "We continue to call on China to share the data and conduct the studies that we have requested, to better understand the origins of this virus," said Tedros. Also read | China says impossible to 'accurately grasp' the actual number of Covid infected people The first cases of this deadly virus were identified in the Chinese city of Wuhan. As per Tedros "all hypotheses remain on the table" including the one that alleges that the virus may have escaped from Wuhan's virology laboratories. A meeting of the WHO emergency committee that advises Tedros on whether a virus constitutes a public health emergency of international concern (PHEIC) will discuss the criteria for ending the coronavirus emergency phase. Also read | In view of mutations, Covid should be renamed, says Chinese medicine expert The WHO COVID-19 technical lead, Maria Van Kerkhove said that while waves of infection are still expected "it is not what it was in the beginning". The upcoming January committee meeting will look at COVID-19 and its subvariants along with their epidemiology. As per Van Kerkhove now the deaths are mainly among unvaccinated people or those who are missing a full course of the life-saving vaccines. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

WHO hopes Covid-19 won't be a public emergency in 2023, says seeking information on virus origins from China

Artificial sweeteners are hailed as healthier alternatives to sugar by most public health organisations. But how healthy are these substitutes? A W.H.O. study has found startling results. Molly Gambhir tells you more.

Gravitas: How healthy are artificial sweeteners?

Lapses in strategies to tackle&nbsp;COVID-19 this year continue to&nbsp;create&nbsp;"the perfect conditions" for a&nbsp;deadly&nbsp;new&nbsp;variant&nbsp;to emerge, the World Health Organization's Director-General Tedros Adhanom Ghebreyesus said on Friday (December 2).

With the peak of the pandemic behind, countries worldwide are starting to loosen the reins on surveillance, testing and vaccination for the disease which has claimed more than 6 million lives so far.

About 90 per cent&nbsp;of the world's population now has some level of immunity to SARS-COV-2 either due to prior infection or vaccination, according to the global health agency's estimates.

"We are much closer to being able to say that the emergency phase of the pandemic is over, but we're not there yet," Tedros told reporters during a press conference.

His comments come as China experiences a rebound in infections.

The further easing of&nbsp;COVID-19 testing requirements and quarantine rules in some Chinese cities was met with a mix of relief and worry on Friday, as hundreds of millions await an expected shift in national virus policies after widespread social unrest.

It was encouraging that China was adjusting its current&nbsp;COVID-19 control strategies,&nbsp;WHO's emergencies director Mike Ryan said.

Ryan said he hopes that a coherent and clear strategy emerges in China "that balances the control of the virus with ... the livelihoods, wellbeing and human rights of the people."

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

Lapses in strategies to tackle COVID-19 this year continue to create "the perfect conditions" for a deadly new variant to emerge, the World Health Organization's Director-General Tedros Adhanom Ghebreyesus said on Friday (December 2).

Lapses in strategies to tackle COVID-19 this year continue to create "the perfect conditions" for a deadly new variant to emerge, the World Health Organization's Director-General Tedros Adhanom Ghebreyesus said on Friday (December 2). With the peak of the pandemic behind, countries worldwide are starting to loosen the reins on surveillance, testing and vaccination for the disease which has claimed more than 6 million lives so far. About 90 per cent of the world's population now has some level of immunity to SARS-COV-2 either due to prior infection or vaccination, according to the global health agency's estimates. "We are much closer to being able to say that the emergency phase of the pandemic is over, but we're not there yet," Tedros told reporters during a press conference. His comments come as China experiences a rebound in infections. The further easing of COVID-19 testing requirements and quarantine rules in some Chinese cities was met with a mix of relief and worry on Friday, as hundreds of millions await an expected shift in national virus policies after widespread social unrest. It was encouraging that China was adjusting its current COVID-19 control strategies, WHO's emergencies director Mike Ryan said. Ryan said he hopes that a coherent and clear strategy emerges in China "that balances the control of the virus with ... the livelihoods, wellbeing and human rights of the people." WATCH WION LIVE HERE

Drop in Covid alertness could create deadly new variant, says WHO

The World Health Organization said on Friday that it was happy that China has decided to loosen some of its COVID-19 restrictions in the aftermath of protests all around the country.

"We're pleased to learn that the Chinese authorities are adjusting their current strategies and really trying to calibrate now the control measures they need... with the lives, the livelihoods and the human rights of people," WHO emergencies director Michael Ryan said at a press conference.

Also read |&nbsp;<a href="https://www.wionews.com/world/china-to-implement-emergency-level-censorship-over-zero-covid-protests-report-539404">China to implement ‘emergency’ level censorship over zero-Covid protests</a>

"It's really important that governments listen to their people when people are in pain," he added.

European Union chief Charles Michel spoke to Chinese President Xi Jinping about the protests and the tough restrictions imposed as part of the zero-Covid policy. Michel told the media that Beijing has hinted at decreasing the restrictions in the wake of a less dangerous Covid strain.

According to AFP, Xi told Michel that Chinese "people were frustrated" after three years of the pandemic and the protests are an expression of the displeasure. While China did not agree with the European model of avoiding lockdowns, Xi suggested that few restrictions will be removed.

Also read |&nbsp;<a href="https://www.wionews.com/south-asia/shehbaz-sharif-condemns-assassination-attempt-on-pakistans-head-of-mission-to-afghanistan-in-kabul-539484">'Assassination attempt': Sharif condemns attack on Pak's mission head in Kabul</a>

"It was mainly students or teenagers in university. That's the explanation that was given," one senior European official said, speaking on condition of anonymity about what Xi said in the meeting.

"As the president explained to President Xi, in Europe we'd initially in the first phase of dealing with Covid focused very much on isolation, quarantine and testing, but over a period of time that has evolved in particular to a very large focus on vaccination,” another source told AFP.

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organization said on Friday that it was happy that China has decided to loosen some of its COVID-19 restrictions in the aftermath of protests all around the country.

The World Health Organization said on Friday that it was happy that China has decided to loosen some of its COVID-19 restrictions in the aftermath of protests all around the country. "We're pleased to learn that the Chinese authorities are adjusting their current strategies and really trying to calibrate now the control measures they need... with the lives, the livelihoods and the human rights of people," WHO emergencies director Michael Ryan said at a press conference. Also read | China to implement ‘emergency’ level censorship over zero-Covid protests "It's really important that governments listen to their people when people are in pain," he added. European Union chief Charles Michel spoke to Chinese President Xi Jinping about the protests and the tough restrictions imposed as part of the zero-Covid policy. Michel told the media that Beijing has hinted at decreasing the restrictions in the wake of a less dangerous Covid strain. According to AFP, Xi told Michel that Chinese "people were frustrated" after three years of the pandemic and the protests are an expression of the displeasure. While China did not agree with the European model of avoiding lockdowns, Xi suggested that few restrictions will be removed. Also read | 'Assassination attempt': Sharif condemns attack on Pak's mission head in Kabul "It was mainly students or teenagers in university. That's the explanation that was given," one senior European official said, speaking on condition of anonymity about what Xi said in the meeting. "As the president explained to President Xi, in Europe we'd initially in the first phase of dealing with Covid focused very much on isolation, quarantine and testing, but over a period of time that has evolved in particular to a very large focus on vaccination,” another source told AFP.

WHO 'pleased' to see China ease zero-Covid restrictions following massive protests

The World Health Organisation has renamed Monkeypox to Mpox after receiving complaints against the disease's name being 'racist and stigmatising.' Neha Khanna brings you more details.

WION Fineprint: Monkeypox gets new name Mpox

The World Health Organisation (WHO) has decided to rename Monkeypox to mpox in English to avoid the stigma existing to the current name. In the past year, the name has sparked a lot of controversy for the alleged racial undertone and its usage as a slur in various parts of the world.

The name “Monkeypox” was given in Denmark back in 1958 after the virus was identified in monkeys during research. While the name can suggest that it is found mostly in monkeys, the virus is actually found in several animals with rodents accounting for the most cases every year.

Also read |&nbsp;<a href="https://www.wionews.com/world/china-says-forces-with-ulterior-motives-are-linking-urumqi-fire-with-covid-curbs-538123">Beijing blames 'forces with ulterior motives' for fuelling rage in the country</a>

"Following a series of consultations with global experts, WHO will begin using a new preferred term 'mpox' as a synonym for monkeypox. Both names will be used simultaneously for one year while 'monkeypox' is phased out," the United Nations health agency said in its official statement.

"WHO will adopt the term mpox in its communications, and encourages others to follow these recommendations, to minimise any ongoing negative impact of the current name and from adoption of the new name," the statement added according to a report by AFP.

Also read |&nbsp;<a href="https://www.wionews.com/world/europol-takes-down-european-super-cartel-with-six-major-arrests-in-dubai-538168">Europol takes down cocaine 'super cartel' with six major arrests in Dubai</a>

The first human case was found in the Democratic Republic of Congo and due to the huge rise of cases in Africa, the name became a topic of controversy. Later, the cases were found outside Africa and in the past year, a number of countries in Europe have also seen a huge surge in infections.

According to official data, more than 81,000 cases have been reported in 2022 from 110 countries.

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organisation (WHO) has decided to rename Monkeypox to mpox in English to avoid the stigma existing to the current name. In the past year, the name has sparked a lot of controversy for the alleged racial undertone and its usage as a slur in various parts of the world.

The World Health Organisation (WHO) has decided to rename Monkeypox to mpox in English to avoid the stigma existing to the current name. In the past year, the name has sparked a lot of controversy for the alleged racial undertone and its usage as a slur in various parts of the world. The name “Monkeypox” was given in Denmark back in 1958 after the virus was identified in monkeys during research. While the name can suggest that it is found mostly in monkeys, the virus is actually found in several animals with rodents accounting for the most cases every year. Also read | Beijing blames 'forces with ulterior motives' for fuelling rage in the country "Following a series of consultations with global experts, WHO will begin using a new preferred term 'mpox' as a synonym for monkeypox. Both names will be used simultaneously for one year while 'monkeypox' is phased out," the United Nations health agency said in its official statement. "WHO will adopt the term mpox in its communications, and encourages others to follow these recommendations, to minimise any ongoing negative impact of the current name and from adoption of the new name," the statement added according to a report by AFP. Also read | Europol takes down cocaine 'super cartel' with six major arrests in Dubai The first human case was found in the Democratic Republic of Congo and due to the huge rise of cases in Africa, the name became a topic of controversy. Later, the cases were found outside Africa and in the past year, a number of countries in Europe have also seen a huge surge in infections. According to official data, more than 81,000 cases have been reported in 2022 from 110 countries.

WHO to use new preferred term ‘mpox’ for ‘Monkeypox’ virus to avoid stigma

The World Health Organization (WHO) and&nbsp;US Health agency, the&nbsp;Centers for Disease Control and Prevention (CDC) warned on Wednesday that the world now faces an impending threat of measles spreading in numerous locations internationally due to the COVID-19 pandemic's ongoing impact on vaccine coverage and impaired disease surveillance.

As per a joint report issued by the two organisations, a record 40 million children missed a vaccination dose for measles in the year 2021. It chalks this up to hurdles created by the COVID-19 pandemic.

Watch |&nbsp;UNICEF warns against global measles outbreaks after cases surge across the globe

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/unicef-warns-against-global-measles-outbreaks-after-cases-surge-across-the-globe-474750/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

Talking to Reuters, Patrick O'Connor, World Health Organization's measles lead said that while compared to previous years the number of measles cases has not gone up dramatically, the time to act is now.

"We are at a crossroads," he remarked, adding that the next 12-24 months are going to be very challenging, as the world tries to mitigate the situation.

Also read |&nbsp;<a href="https://www.wionews.com/world/over-685-dead-in-zimbabwe-due-to-measles-outbreak-anti-vaxxers-remain-a-roadblock-512693">700 children dead in Zimbabwe due to measles outbreak, anti-vaxxers remain a roadblock</a>

He said that even though there are growing immunity gaps, there have not yet been an overwhelming number of cases. As per him, this may be due to a combination of factors including the cyclical nature of the disease and lingering social isolation policies.

O'Connor warned that this could change quickly given the highly contagious nature of the illness.

Also read |&nbsp;<a href="https://www.wionews.com/science/cases-of-measles-have-increased-by-80-and-other-diseases-may-follow-un-474732">Cases of measles have increased by 80%, and other diseases may follow: UN</a>

He further noted that since the beginning of 2022, the number of "large disruptive outbreaks" had increased, climbing from 19 to over 30 by September. He added that he was especially concerned about certain regions of sub-Saharan Africa.

Measles is one of the most contagious human viruses, although it is nearly fully preventable with immunisation. Nevertheless, to stop outbreaks among communities, there must be 95 per cent vaccination coverage.

The World Health Organization (WHO) and US Health agency, the Centers for Disease Control and Prevention (CDC) warned on Wednesday that the world now faces an impending threat of measles spreading in numerous locations internationally due to the COVID-19 pandemic's ongoing impact on vaccine coverage and impaired disease surveillance.

The World Health Organization (WHO) and US Health agency, the Centers for Disease Control and Prevention (CDC) warned on Wednesday that the world now faces an impending threat of measles spreading in numerous locations internationally due to the COVID-19 pandemic's ongoing impact on vaccine coverage and impaired disease surveillance. As per a joint report issued by the two organisations, a record 40 million children missed a vaccination dose for measles in the year 2021. It chalks this up to hurdles created by the COVID-19 pandemic. Watch | UNICEF warns against global measles outbreaks after cases surge across the globe Talking to Reuters, Patrick O'Connor, World Health Organization's measles lead said that while compared to previous years the number of measles cases has not gone up dramatically, the time to act is now. "We are at a crossroads," he remarked, adding that the next 12-24 months are going to be very challenging, as the world tries to mitigate the situation. Also read | 700 children dead in Zimbabwe due to measles outbreak, anti-vaxxers remain a roadblock He said that even though there are growing immunity gaps, there have not yet been an overwhelming number of cases. As per him, this may be due to a combination of factors including the cyclical nature of the disease and lingering social isolation policies. O'Connor warned that this could change quickly given the highly contagious nature of the illness. Also read | Cases of measles have increased by 80%, and other diseases may follow: UN He further noted that since the beginning of 2022, the number of "large disruptive outbreaks" had increased, climbing from 19 to over 30 by September. He added that he was especially concerned about certain regions of sub-Saharan Africa. Measles is one of the most contagious human viruses, although it is nearly fully preventable with immunisation. Nevertheless, to stop outbreaks among communities, there must be 95 per cent vaccination coverage.

40mn children missed measles vaccine in 2021; disease is now an imminent global threat, warn CDC and WHO

The World Health Organization (WHO) is planning to rename monkeypox as “MPOX”, Politico reported citing people familiar with the matter.

The US news outlet reported that a decision on the same would be announced as early as Friday.

The move is being undertaken to destigmatise the virus that was reported in more than 70 countries earlier this year.

It reportedly comes in response to growing pressure from the Biden administration, who is said to have privately nudged the WHO officials to change the name. It is said that the US warned it could act unilaterally if the world health agency did not pay heed to their suggestion.

For months, the Biden administration believed that the virus’ name was deepening stigma, especially among people of colour, and slowed down the vaccination campaign, the newspaper reported.

There were campaigns spearheaded by public health experts and LGBT activists calling for a change in the virus’ name. They argued that calling it monkeypox is inaccurate and permeates&nbsp;already existing racist stereotypes about Africa and is detrimental to the global response.

Also read |&nbsp;<a href="https://www.wionews.com/world/indonesian-president-announces-compensation-for-quake-victims-as-search-for-survivors-continues-536364">Indonesia quake toll rises to 268, 151 still missing, over 58,000 displaced</a>

“In the context of the current global outbreak, continued reference to, and nomenclature of this virus being African is not only inaccurate but is also discriminatory and stigmatizing,” a group of scientists wrote in&nbsp;a joint statement published&nbsp;in June.

Also read |&nbsp;<a href="https://www.wionews.com/world/brazils-bolsonaro-contests-election-results-alleges-voting-machines-had-signs-of-serious-failures-536593">Brazil's Bolsonaro contests election results, alleges voting machines had 'signs of serious failures'</a>

Monkeypox, which is a relatively mild viral illness, is endemic in several countries in western and central Africa. But it was reported around the world earlier this year.

US Center for Disease Control and Prevention estimates that there are more than 80,000 cases worldwide, with the cases mainly emanating from having same-sex relationships. US had recorded nearly 30, 000 infections.

(With inputs from agencies)

WATCH WION LIVE HERE: 

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organization (WHO) is planning to rename monkeypox as “MPOX”, Politico reported citing people familiar with the matter. The US news outlet reported that a decision on the same would be announced as early as Friday.

The World Health Organization (WHO) is planning to rename monkeypox as “MPOX”, Politico reported citing people familiar with the matter. The US news outlet reported that a decision on the same would be announced as early as Friday. The move is being undertaken to destigmatise the virus that was reported in more than 70 countries earlier this year. It reportedly comes in response to growing pressure from the Biden administration, who is said to have privately nudged the WHO officials to change the name. It is said that the US warned it could act unilaterally if the world health agency did not pay heed to their suggestion. For months, the Biden administration believed that the virus’ name was deepening stigma, especially among people of colour, and slowed down the vaccination campaign, the newspaper reported. There were campaigns spearheaded by public health experts and LGBT activists calling for a change in the virus’ name. They argued that calling it monkeypox is inaccurate and permeates already existing racist stereotypes about Africa and is detrimental to the global response. Also read | Indonesia quake toll rises to 268, 151 still missing, over 58,000 displaced “In the context of the current global outbreak, continued reference to, and nomenclature of this virus being African is not only inaccurate but is also discriminatory and stigmatizing,” a group of scientists wrote in a joint statement published in June. Also read | Brazil's Bolsonaro contests election results, alleges voting machines had 'signs of serious failures' Monkeypox, which is a relatively mild viral illness, is endemic in several countries in western and central Africa. But it was reported around the world earlier this year. US Center for Disease Control and Prevention estimates that there are more than 80,000 cases worldwide, with the cases mainly emanating from having same-sex relationships. US had recorded nearly 30, 000 infections. (With inputs from agencies) WATCH WION LIVE HERE:

WHO to rename monkeypox as ‘MPOX’ over stigma, pressure from US: Report

<h2>Why 14 November as World Diabetes Day?&nbsp;</h2>

14 November was designated by the United Nations General Assembly (UNGA) as World Diabetes Day in 2007, a day that started a global awareness campaign focusing on the disease. It was led by World Health Organization (WHO) and International Diabetes Federation (IDF) with a focused theme on type-2 diabetes, which is rapidly increasing in adults worldwide.

The day of 14 November was chosen as World Diabetes Day to commemorate the birthday of Sir Frederick Banting, co-discoverer of Insulin along with Charles Best in 1922. This year's theme, ‘Access to Diabetes Education’, strengthens the larger multi-year theme of 'access to care'.

<h2>What is Diabetes and its types?</h2>

Diabetes is a non-communicable chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood glucose. It is also known as diabetes mellitus, and, if left untreated can cause many health complications. It can cause serious long-term complications like cardiovascular disease, stroke, chronic kidney disease, foot ulcers, damage to the nerves, damage to the eyes, and cognitive impairment.&nbsp;

As per the data of WHO, in 2014, 8.5% of adults aged 18 years and older had diabetes and in 2019, diabetes was the direct cause of 1.5 million deaths. And 48% of all deaths due to diabetes occurred before the age of 70 years.

Also Read |&nbsp;<a href="https://www.wionews.com/science/dietary-supplements-for-heart-health-dont-work-study-532000">Study shows that dietary supplements are ineffective for heart health</a>

There are two&nbsp;main types of diabetes from which a person can be diagnosed: 
&nbsp;

Type 1 diabetes: It is characterised by a lack of insulin production in the body. According to WHO, in 2017 there were 9 million people with type 1 diabetes and the majority of them were from high-income countries. Neither its cause nor the means to prevent it are known yet.

Symptoms can include excessive excretion of urine, thirst, constant hunger, weight loss, vision changes, and fatigue. These symptoms may occur suddenly.

Type 2 diabetes: Formerly called non-insulin-dependent or adult-onset diabetes, is caused by the body’s ineffective use of insulin. It often results from excess body weight and physical inactivity. Earlier, this type of diabetes was seen only in adults but it is now also occurring frequently in children.&nbsp;

Symptoms may be similar to those of type 1 diabetes but are often less evident. As a result, the disease may be diagnosed several years after its onset, causing complications to rise to higher levels.

<h2>Foods to avoid on diabetes:</h2>

1. Sugar-sweetened beverages like soda, cola&nbsp; 
2. White bread, rice and pasta 
3. Fruit-flavoured yoghurt 
4. Flavoured coffee drinks 
5. Packaged snack food&nbsp;

<h2>Diagnosis and Treatment:</h2>

Early diagnosis can be accomplished through relatively inexpensive testing of blood glucose. Treatment of diabetes involves diet and physical activity along with lowering of blood glucose that damages blood vessels:

People with type 1 diabetes require insulin, and people with type 2 diabetes can be treated with oral medication, but may also require insulin, blood pressure control, and foot care (patient self-care by maintaining foot hygiene, wearing appropriate footwear, seeking professional care for ulcer management, and regular examination of feet by health professionals).

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

&nbsp;

&nbsp;

&nbsp;

&nbsp;

&nbsp;

Why 14 November as World Diabetes Day? 14 November was designated by the United Nations General Assembly (UNGA) as World Diabetes Day in 2007, a day that started a global awareness campaign focusing on the disease.

Why 14 November as World Diabetes Day? 14 November was designated by the United Nations General Assembly (UNGA) as World Diabetes Day in 2007, a day that started a global awareness campaign focusing on the disease. It was led by World Health Organization (WHO) and International Diabetes Federation (IDF) with a focused theme on type-2 diabetes, which is rapidly increasing in adults worldwide. The day of 14 November was chosen as World Diabetes Day to commemorate the birthday of Sir Frederick Banting, co-discoverer of Insulin along with Charles Best in 1922. This year's theme, ‘Access to Diabetes Education’, strengthens the larger multi-year theme of 'access to care'. What is Diabetes and its types? Diabetes is a non-communicable chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood glucose. It is also known as diabetes mellitus, and, if left untreated can cause many health complications. It can cause serious long-term complications like cardiovascular disease, stroke, chronic kidney disease, foot ulcers, damage to the nerves, damage to the eyes, and cognitive impairment. As per the data of WHO, in 2014, 8.5% of adults aged 18 years and older had diabetes and in 2019, diabetes was the direct cause of 1.5 million deaths. And 48% of all deaths due to diabetes occurred before the age of 70 years. Also Read | Study shows that dietary supplements are ineffective for heart health There are two main types of diabetes from which a person can be diagnosed: Type 1 diabetes: It is characterised by a lack of insulin production in the body. According to WHO, in 2017 there were 9 million people with type 1 diabetes and the majority of them were from high-income countries. Neither its cause nor the means to prevent it are known yet. Symptoms can include excessive excretion of urine, thirst, constant hunger, weight loss, vision changes, and fatigue. These symptoms may occur suddenly. Type 2 diabetes: Formerly called non-insulin-dependent or adult-onset diabetes, is caused by the body’s ineffective use of insulin. It often results from excess body weight and physical inactivity. Earlier, this type of diabetes was seen only in adults but it is now also occurring frequently in children. Symptoms may be similar to those of type 1 diabetes but are often less evident. As a result, the disease may be diagnosed several years after its onset, causing complications to rise to higher levels. Foods to avoid on diabetes: 1. Sugar-sweetened beverages like soda, cola 2. White bread, rice and pasta 3. Fruit-flavoured yoghurt 4. Flavoured coffee drinks 5. Packaged snack food Diagnosis and Treatment: Early diagnosis can be accomplished through relatively inexpensive testing of blood glucose. Treatment of diabetes involves diet and physical activity along with lowering of blood glucose that damages blood vessels: People with type 1 diabetes require insulin, and people with type 2 diabetes can be treated with oral medication, but may also require insulin, blood pressure control, and foot care (patient self-care by maintaining foot hygiene, wearing appropriate footwear, seeking professional care for ulcer management, and regular examination of feet by health professionals). WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

World Diabetes Day 2022: What you need to know about the condition

Hot weather has resulted in the death of at least 15,000 people in Europe so far this year, said the World Health Organization on Monday.&nbsp;

The three months from June through August were the hottest for Europe since records began, and the exceptionally high temperatures caused the worst drought the continent has seen since the Middle Ages, according to the organisation.&nbsp;

Watch |&nbsp;WION Climate Tracker: Europe warming at twice the global average

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/wion-climate-tracker-europe-warming-at-twice-the-global-average-531279/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

As per AFP, around 24,000 excess deaths occurred in Europe during a series of heatwaves that occurred between June and July, when temperatures in Britain reached a record-breaking 40 degrees Celsius (104 degrees Fahrenheit).

Quoting data, the WHO's Regional Director for Europe, Hans Kluge, said that at least 15,000 deaths in 2022 were specifically related to the heat.

Also read |&nbsp;<a href="https://www.wionews.com/world/cop27-past-eight-years-were-the-hottest-ever-in-history-says-united-nations-531682" hreflang="en">COP27: Past eight years were the hottest ever in history, says United Nations</a>

"Based on country data submitted so far, it is estimated that at least 15,000 people died specifically due to the heat in 2022."

Spain and Germany are among the countries worst affected by the weather phenomenon.

Kluge noted that over the three months of the summer, health authorities reported "nearly 4,000 deaths in Spain, more than 1,000 in Portugal, more than 3,200 in the United Kingdom, and around 4,500 deaths in Germany."

Also read |&nbsp;<a href="https://www.wionews.com/world/siberian-winds-will-be-particularly-chilly-this-winter-can-west-cope-with-eastern-beast-amid-energy-crisis-531620" hreflang="en">Siberian winds will be particularly chilly this winter. Can West cope with 'Eastern Beast' amid energy crisis?</a>

As more nations report on excessive heat-related mortality, "this estimate is expected to increase," he warned.

The historic dry season spurred record wildfire intensity and put tremendous strain on the continent's electricity supply, causing crops to wither in the "breadbaskets" of Europe.

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Hot weather has resulted in the death of at least 15,000 people in Europe so far this year, said the World Health Organization on Monday. The three months from June through August were the hottest for Europe since records began, and the exceptionally high temperatures caused the worst drought the continent has seen since the Middle Ages, according to the organisation.

Hot weather has resulted in the death of at least 15,000 people in Europe so far this year, said the World Health Organization on Monday. The three months from June through August were the hottest for Europe since records began, and the exceptionally high temperatures caused the worst drought the continent has seen since the Middle Ages, according to the organisation. Watch | WION Climate Tracker: Europe warming at twice the global average As per AFP, around 24,000 excess deaths occurred in Europe during a series of heatwaves that occurred between June and July, when temperatures in Britain reached a record-breaking 40 degrees Celsius (104 degrees Fahrenheit). Quoting data, the WHO's Regional Director for Europe, Hans Kluge, said that at least 15,000 deaths in 2022 were specifically related to the heat. Also read | COP27: Past eight years were the hottest ever in history, says United Nations "Based on country data submitted so far, it is estimated that at least 15,000 people died specifically due to the heat in 2022." Spain and Germany are among the countries worst affected by the weather phenomenon. Kluge noted that over the three months of the summer, health authorities reported "nearly 4,000 deaths in Spain, more than 1,000 in Portugal, more than 3,200 in the United Kingdom, and around 4,500 deaths in Germany." Also read | Siberian winds will be particularly chilly this winter. Can West cope with 'Eastern Beast' amid energy crisis? As more nations report on excessive heat-related mortality, "this estimate is expected to increase," he warned. The historic dry season spurred record wildfire intensity and put tremendous strain on the continent's electricity supply, causing crops to wither in the "breadbaskets" of Europe. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

In 2022, Europe experienced the worst drought since the Middle Ages; it killed around 15,000 people: WHO

Tuberculosis&nbsp;has rebounded after years of decline, killing an estimated 1.6 million people in 2021, up 14 percent in two years, new World Health Organization figures showed Thursday.

TB, which was overtaken by Covid-19 during the worst of the pandemic as the world's biggest infectious killer, claimed an estimated 1.5 million lives in 2020 and 1.4 million in 2019.

And the WHO blamed the resurgence of the disease on the pandemic, saying the crisis had had a huge and ongoing impact on access to diagnosis and treatment.

"Globally, the annual estimated number of deaths from TB fell between 2005 and 2019, but the estimates for 2020 and 2021 suggest that this trend has been reversed," the UN's health agency said in its annual Global TB report.

Most of the estimated increase in TB deaths globally was accounted for by four countries: India, Indonesia, Myanmar and the Philippines.

The report said it was possible that TB would "once again be the leading cause of death worldwide from a single infectious agent, replacing Covid-19".

But Mel Spigelman, president of the non-profit TB Alliance, told AFP last week that that had already happened, comparing the annual TB death rate to the latest Covid-19 figures.

An estimated 10.6 million people fell ill with TB in 2021 -- a 4.5 percent increase on 2020, the WHO said.

"This is the first time in many years an increase has been reported in the number of people falling ill with TB and drug resistant TB," the WHO said.

And the incidence rate -- new cases per 100,000 population per year -- increased by 3.6 percent between 2020 and 2021, after declining by around two percent a year for most of the last two decades.

Progress dented

"The overarching finding of this report is that the Covid-19 pandemic continues to have a damaging impact on access to TB diagnosis and treatment and the burden of TB disease," the WHO update said.

"Progress made in the years up to 2019 has slowed, stalled or reversed, and global TB targets are off track.

"Intensified efforts backed by increased funding are urgently required to mitigate and reverse the negative impacts of the pandemic on TB."

Tuberculosis&nbsp;is caused by a bacteria that most often affects the lungs.&nbsp;Like Covid, it is transmitted via the air by infected people, for example by coughing. It is preventable and curable.

The WHO said conflicts around the world, the global energy crisis and associated risks to food security were likely to worsen the situation further.

"The top priority is to restore access to and provision of essential TB services, so that levels of TB case detection and treatment can recover to at least 2019 levels," the report said.

Eight countries accounted for more than two thirds of the global total of cases: India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh and the Democratic Republic of Congo.

"If the pandemic has taught us anything, it's that with solidarity, determination, innovation and the equitable use of tools, we can overcome severe health threats," said WHO chief Tedros Adhanom Ghebreyesus.

"Let's apply those lessons to&nbsp;tuberculosis. It is time to put a stop to this long-time killer. Working together, we can end TB."

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Tuberculosis has rebounded after years of decline, killing an estimated 1.6 million people in 2021, up 14 percent in two years, new World Health Organization figures showed Thursday.

Tuberculosis has rebounded after years of decline, killing an estimated 1.6 million people in 2021, up 14 percent in two years, new World Health Organization figures showed Thursday. TB, which was overtaken by Covid-19 during the worst of the pandemic as the world's biggest infectious killer, claimed an estimated 1.5 million lives in 2020 and 1.4 million in 2019. And the WHO blamed the resurgence of the disease on the pandemic, saying the crisis had had a huge and ongoing impact on access to diagnosis and treatment. "Globally, the annual estimated number of deaths from TB fell between 2005 and 2019, but the estimates for 2020 and 2021 suggest that this trend has been reversed," the UN's health agency said in its annual Global TB report. Most of the estimated increase in TB deaths globally was accounted for by four countries: India, Indonesia, Myanmar and the Philippines. The report said it was possible that TB would "once again be the leading cause of death worldwide from a single infectious agent, replacing Covid-19". But Mel Spigelman, president of the non-profit TB Alliance, told AFP last week that that had already happened, comparing the annual TB death rate to the latest Covid-19 figures. An estimated 10.6 million people fell ill with TB in 2021 -- a 4.5 percent increase on 2020, the WHO said. "This is the first time in many years an increase has been reported in the number of people falling ill with TB and drug resistant TB," the WHO said. And the incidence rate -- new cases per 100,000 population per year -- increased by 3.6 percent between 2020 and 2021, after declining by around two percent a year for most of the last two decades. Progress dented "The overarching finding of this report is that the Covid-19 pandemic continues to have a damaging impact on access to TB diagnosis and treatment and the burden of TB disease," the WHO update said. "Progress made in the years up to 2019 has slowed, stalled or reversed, and global TB targets are off track. "Intensified efforts backed by increased funding are urgently required to mitigate and reverse the negative impacts of the pandemic on TB." Tuberculosis is caused by a bacteria that most often affects the lungs. Like Covid, it is transmitted via the air by infected people, for example by coughing. It is preventable and curable. The WHO said conflicts around the world, the global energy crisis and associated risks to food security were likely to worsen the situation further. "The top priority is to restore access to and provision of essential TB services, so that levels of TB case detection and treatment can recover to at least 2019 levels," the report said. Eight countries accounted for more than two thirds of the global total of cases: India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh and the Democratic Republic of Congo. "If the pandemic has taught us anything, it's that with solidarity, determination, innovation and the equitable use of tools, we can overcome severe health threats," said WHO chief Tedros Adhanom Ghebreyesus. "Let's apply those lessons to tuberculosis. It is time to put a stop to this long-time killer. Working together, we can end TB." WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Tuberculosis firmly on the rise after years of decline: WHO

The World Health Organization&nbsp;(WHO) has&nbsp;released a list of more than a dozen fungus that are dangerous to the general public's health.

The global health organisation has identified 19 "priority pathogens" that include yeasts and moulds and are evolving and becoming resistant to treatments, as reported by The Daily Mail.&nbsp;

Over 150 million serious infections and over 1.7 million fatalities globally are annually attributed to fungus infections.

However, during the pandemic, the infections—which proliferated in hospitals and can be fatal for patients with compromised immune systems—became increasingly widespread.

The pathogens target individuals with compromised immune systems, such as those who are battling <a href="https://www.wionews.com/world/covid-flare-up-at-worlds-largest-iphone-factory-in-china-affects-operations-528785">COVID-19</a>. Steroids are one of the Covid treatments that can make the body's defences against fungus even weaker.

A comparable list of the most deadly bacteria is published by the WHO, which also created a list of dangerous fungus due to a general lack of funding for their research.

Also read |&nbsp;<a href="https://www.wionews.com/world/cities-in-china-tighten-measures-to-combat-growing-covid-19-outbreaks-528777">China: Wuhan, Guangzhou and other cities tighten measures to combat growing COVID-19 outbreaks</a>

According to the WHO, fungus-related infections continue to pose a serious threat to the public's health despite inadequate funding being allocated to their research.

There have historically been gaps in our understanding of diagnostics and effective therapies due to a lack of research on fungal pathogens.

Dr Hanan Balkhy, the WHO's assistant director-general, antimicrobial resistance (AMR) said: 'Emerging from the shadows of the bacterial antimicrobial resistance pandemic, fungal infections are growing, and are ever more resistant to treatments, becoming a public health concern worldwide.'

The health organisation encouraged nations to strengthen their mechanisms for detecting the 19 types of hazardous fungi and taking action.

According to Dr. Haileyesus Getahun, Director of the WHO's AMR Global Coordination Department, "Countries are encouraged to follow a step-by-step approach, starting with strengthening their fungal disease laboratory and surveillance capacities, and ensuring equitable access to existing quality therapeutics and diagnostics, globally."

Also read |&nbsp;<a href="https://www.wionews.com/science/bees-order-numbers-in-increasing-size-from-left-to-right-study-reveals-528769">Bees 'count' numbers in increasing size from left to right, study reveals</a>

Because of the planet's ongoing warming, fungi have had to evolve in ways that make them better at spreading disease to humans.

The characteristics of the fungus, its habitat, and its host change as a result of global warming, increasing the possibility that new fungi varieties will appear.

The scientific community applauded the WHO report, describing it as a step in the right direction for developing new ways to treat fungal infections that are resistant to treatment.

WATCH WION LIVE HERE:

<iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed" style="width:100%;max-width:560px;" width="560"></iframe>

The World Health Organization (WHO) has released a list of more than a dozen fungus that are dangerous to the general public's health. The global health organisation has identified 19 "priority pathogens" that include yeasts and moulds and are evolving and becoming resistant to treatments, as reported by The Daily Mail.

The World Health Organization (WHO) has released a list of more than a dozen fungus that are dangerous to the general public's health. The global health organisation has identified 19 "priority pathogens" that include yeasts and moulds and are evolving and becoming resistant to treatments, as reported by The Daily Mail. Over 150 million serious infections and over 1.7 million fatalities globally are annually attributed to fungus infections. However, during the pandemic, the infections—which proliferated in hospitals and can be fatal for patients with compromised immune systems—became increasingly widespread. The pathogens target individuals with compromised immune systems, such as those who are battling COVID-19. Steroids are one of the Covid treatments that can make the body's defences against fungus even weaker. A comparable list of the most deadly bacteria is published by the WHO, which also created a list of dangerous fungus due to a general lack of funding for their research. Also read | China: Wuhan, Guangzhou and other cities tighten measures to combat growing COVID-19 outbreaks According to the WHO, fungus-related infections continue to pose a serious threat to the public's health despite inadequate funding being allocated to their research. There have historically been gaps in our understanding of diagnostics and effective therapies due to a lack of research on fungal pathogens. Dr Hanan Balkhy, the WHO's assistant director-general, antimicrobial resistance (AMR) said: 'Emerging from the shadows of the bacterial antimicrobial resistance pandemic, fungal infections are growing, and are ever more resistant to treatments, becoming a public health concern worldwide.' The health organisation encouraged nations to strengthen their mechanisms for detecting the 19 types of hazardous fungi and taking action. According to Dr. Haileyesus Getahun, Director of the WHO's AMR Global Coordination Department, "Countries are encouraged to follow a step-by-step approach, starting with strengthening their fungal disease laboratory and surveillance capacities, and ensuring equitable access to existing quality therapeutics and diagnostics, globally." Also read | Bees 'count' numbers in increasing size from left to right, study reveals Because of the planet's ongoing warming, fungi have had to evolve in ways that make them better at spreading disease to humans. The characteristics of the fungus, its habitat, and its host change as a result of global warming, increasing the possibility that new fungi varieties will appear. The scientific community applauded the WHO report, describing it as a step in the right direction for developing new ways to treat fungal infections that are resistant to treatment. WATCH WION LIVE HERE:

Fatal fungi: WHO publishes first ever list of fungal infections that are 'becoming a threat to humanity'

Zimbabwe has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention, recommended by the World Health Organisation (WHO) earlier this year making it the first African nation and third in the world to do so. Regulators in&nbsp; the United States and Australia have already backed the use of the drug.

“CAB-LA may be offered to people at substantial risk of HIV acquisition as part of comprehensive HIV prevention approaches,”&nbsp;the WHO had previously indicated. In July, the global health agency recommended the drug saying that it is highly effective at reducing the transmission risk among people at most risk of contracting HIV.&nbsp;

The recommendation was reportedly made in light of observing a surge of HIV infections globally.&nbsp;“HIV prevention efforts have stalled, with 1.5 million new HIV infections in 2021…the same as in 2020. There were 4000 new infections every day in 2021, with key populations and their sexual partners accounting for 70% of HIV infections globally.”&nbsp;

ALSO READ:&nbsp;<a href="https://www.wionews.com/world/over-685-dead-in-zimbabwe-due-to-measles-outbreak-anti-vaxxers-remain-a-roadblock-512693">700 children dead in Zimbabwe due to measles outbreak, anti-vaxxers remain a roadblock</a>

The key populations WHO was referring to reportedly include sex workers, men who have sex with men, people who inject drugs, people in prisons, and transgender people. According to the local media, in most African nations, sex workers and people from the LGBTQIA+ community are often overlooked in the context of access to healthcare because of “laws and societal segregation”.&nbsp;

According to WHO, the intramuscular injectable long-acting form of PrEP has to be administered with the first two injections four weeks apart, followed thereafter by an injection every eight weeks. CAB-LA injections every two months are safe and highly effective in reducing the risk of contracting HIV, said the report.&nbsp;

In a statement, the WHO has also welcomed this decision and called it a “crucial step” for the African nation, adding that it&nbsp;would support them “to design and develop programmes so that CAB-LA can be implemented, safely and effectively, for greatest impact”.&nbsp;

ALSO READ:&nbsp;<a href="https://www.wionews.com/science/scientists-have-discovered-africas-oldest-dinosaur-named-mbiresaurus-raathi-in-zimbabwe-512201">Scientists have discovered Africa's oldest dinosaur named Mbiresaurus raathi in Zimbabwe</a>

Zimbabwe has seen AIDS-related deaths fall from at least 130,000 in 2002 to 20,000 in 2021, said media reports. Last year, the country also launched the 90-90-90 initiative which aims to end AIDS&nbsp;by 2030 it refers to 90% of people living with HIV knowing their status, 90% getting antiretroviral treatment and 90% having the virus suppressed.&nbsp;

(With inputs from agencies)

&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Zimbabwe has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention, recommended by the World Health Organisation (WHO) earlier this year making it the first African nation and third in the world to do so.

Zimbabwe has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention, recommended by the World Health Organisation (WHO) earlier this year making it the first African nation and third in the world to do so. Regulators in the United States and Australia have already backed the use of the drug. “CAB-LA may be offered to people at substantial risk of HIV acquisition as part of comprehensive HIV prevention approaches,” the WHO had previously indicated. In July, the global health agency recommended the drug saying that it is highly effective at reducing the transmission risk among people at most risk of contracting HIV. The recommendation was reportedly made in light of observing a surge of HIV infections globally. “HIV prevention efforts have stalled, with 1.5 million new HIV infections in 2021…the same as in 2020. There were 4000 new infections every day in 2021, with key populations and their sexual partners accounting for 70% of HIV infections globally.” ALSO READ: 700 children dead in Zimbabwe due to measles outbreak, anti-vaxxers remain a roadblock The key populations WHO was referring to reportedly include sex workers, men who have sex with men, people who inject drugs, people in prisons, and transgender people. According to the local media, in most African nations, sex workers and people from the LGBTQIA+ community are often overlooked in the context of access to healthcare because of “laws and societal segregation”. According to WHO, the intramuscular injectable long-acting form of PrEP has to be administered with the first two injections four weeks apart, followed thereafter by an injection every eight weeks. CAB-LA injections every two months are safe and highly effective in reducing the risk of contracting HIV, said the report. In a statement, the WHO has also welcomed this decision and called it a “crucial step” for the African nation, adding that it would support them “to design and develop programmes so that CAB-LA can be implemented, safely and effectively, for greatest impact”. ALSO READ: Scientists have discovered Africa's oldest dinosaur named Mbiresaurus raathi in Zimbabwe Zimbabwe has seen AIDS-related deaths fall from at least 130,000 in 2002 to 20,000 in 2021, said media reports. Last year, the country also launched the 90-90-90 initiative which aims to end AIDS by 2030 it refers to 90% of people living with HIV knowing their status, 90% getting antiretroviral treatment and 90% having the virus suppressed. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Zimbabwe becomes first country in Africa to approve HIV prevention drug

Pharmaceutical giant Novartis has signed a licencing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.

The deal will give selected manufacturers the opportunity to develop, manufacture and supply generic versions of nilotinib, a twice-daily oral medication used to treat chronic myeloid leukaemia (CML).

"Access to high-quality cancer medicines is a crucial component of the global health response to the cancer burden," said Charles Gore, head of the Medicines Patent Pool, the United Nations-backed public health organisation working to increase access to life-saving medicines in poorer countries. 
 
ALSO READ:&nbsp;<a href="https://www.wionews.com/science/report-more-accurate-test-for-cervical-cancer-developed-by-scientists-in-uk-austria-526789">Report: More accurate test for cervical cancer developed by scientists in UK, Austria</a>

While the remaining patent period for nilotinib was "relatively short", he said the licencing deal set "a vital precedent that I hope other companies will follow", Gore said in a statement.

Novartis president of global health and sustainability Lutz Hegemann said the company was "proud to be pioneering this new licensing model with MPP".

The drug is listed on the World Health Organization's List of Essential Medicines for the treatment of adults and children over the age of one suffering from CML.

Zeba Aziz, a medical oncologist at Hameed Latif Hospital in Lahore, Pakistan, said nilotinib offers an alternative to people who are resistant or intolerant to imatinib, the first-line treatment for CML -- about 20 per cent of those who contract the disease.

ALSO READ:&nbsp;<a href="https://www.wionews.com/science/study-finds-that-less-than-5-hours-of-sleep-can-lead-to-chronic-illnesses-like-heart-disease-cancer-diabetes-526736">Study finds that less than 5 hours of sleep can lead to chronic illnesses like heart disease, cancer, diabetes</a>

"I am glad more people in (low and middle-income countries) will have access to this essential cancer medicine," she said in the statement.

The licence includes seven middle-income countries: Egypt, Guatemala, Indonesia, Morocco, Pakistan, the Philippines and Tunisia, where patents on the product are pending or in force, MPP said.

The Access to Oncology Medicines (ATOM) Coalition welcomed the deal.

"This is a first for cancer treatment anywhere and demonstrates that the combined efforts of the private and public sectors can pave the way to help save millions of lives," ATOM co-chair Anil D-Cruz said in a separate statement. 
&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Pharmaceutical giant Novartis has signed a licencing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.

Pharmaceutical giant Novartis has signed a licencing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug. The deal will give selected manufacturers the opportunity to develop, manufacture and supply generic versions of nilotinib, a twice-daily oral medication used to treat chronic myeloid leukaemia (CML). "Access to high-quality cancer medicines is a crucial component of the global health response to the cancer burden," said Charles Gore, head of the Medicines Patent Pool, the United Nations-backed public health organisation working to increase access to life-saving medicines in poorer countries. ALSO READ: Report: More accurate test for cervical cancer developed by scientists in UK, Austria While the remaining patent period for nilotinib was "relatively short", he said the licencing deal set "a vital precedent that I hope other companies will follow", Gore said in a statement. Novartis president of global health and sustainability Lutz Hegemann said the company was "proud to be pioneering this new licensing model with MPP". The drug is listed on the World Health Organization's List of Essential Medicines for the treatment of adults and children over the age of one suffering from CML. Zeba Aziz, a medical oncologist at Hameed Latif Hospital in Lahore, Pakistan, said nilotinib offers an alternative to people who are resistant or intolerant to imatinib, the first-line treatment for CML -- about 20 per cent of those who contract the disease. ALSO READ: Study finds that less than 5 hours of sleep can lead to chronic illnesses like heart disease, cancer, diabetes "I am glad more people in (low and middle-income countries) will have access to this essential cancer medicine," she said in the statement. The licence includes seven middle-income countries: Egypt, Guatemala, Indonesia, Morocco, Pakistan, the Philippines and Tunisia, where patents on the product are pending or in force, MPP said. The Access to Oncology Medicines (ATOM) Coalition welcomed the deal. "This is a first for cancer treatment anywhere and demonstrates that the combined efforts of the private and public sectors can pave the way to help save millions of lives," ATOM co-chair Anil D-Cruz said in a separate statement. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

First-ever licencing deal struck for cancer drug

A new report suggests that the lack of exercise and healthy physical activities can cost governments around the world more than $27 billion per year. According to the data provided by the World Health Organisation (WHO), the cases of diabetes, dementia and high blood pressure is expected to skyrocket by the year 2030 and that will increase the budget for health services massively.

The data also showed that regular exercise can end up reducing health risks by almost 30 per cent.

Also read |&nbsp;<a href="https://www.wionews.com/world/uk-inflation-accelerates-to-40-year-high-amid-rising-food-prices-526733">UK inflation accelerates to 40-year high amid rising food prices</a>

In the report, WHO urged the governments to actively encourage the citizens to adopt a healthy lifestyle in order to stop the growth of such diseases. In the aftermath of the COVID-19 pandemic, the healthcare costs have risen around the world and the trend is expected to continue in the future.

“There are few areas in public health … where evidence on required action is so convincing, cost effective and practical,” the global report published by WHO stated.

“A consequence of this ‘inaction’ is that already stretched health systems are burdened with preventable disease today and even more so in the future, and communities fail to benefit from the wider social, environmental and economic benefits associated with more people being more active.”

Also read |&nbsp;<a href="https://www.wionews.com/world/explosions-at-myanmars-insein-prison-kill-8-526689" hreflang="en">Bomb blasts at Myanmar's Insein prison leave 8 dead, 18 injured</a>

While the advantages of exercise and physical activities are quite clear, the WHO noted that governments have not paid much attention to raising awareness. The situation is considerably worse in low-income countries where the standard of living is low and there is a lack of proper healthcare.

Among the 194 countries included in the report, WHO found that less than 50 per cent have a clear national policy when it comes to healthy living, but it is not fully functional in all of those countries.

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

A new report suggests that the lack of exercise and healthy physical activities can cost governments around the world more than $27 billion per year. According to the data provided by the World Health Organisation (WHO), the cases of diabetes, dementia and high blood pressure is expected to skyrocket by the year 2030 and that will increase the budget for health services massively.

A new report suggests that the lack of exercise and healthy physical activities can cost governments around the world more than $27 billion per year. According to the data provided by the World Health Organisation (WHO), the cases of diabetes, dementia and high blood pressure is expected to skyrocket by the year 2030 and that will increase the budget for health services massively. The data also showed that regular exercise can end up reducing health risks by almost 30 per cent. Also read | UK inflation accelerates to 40-year high amid rising food prices In the report, WHO urged the governments to actively encourage the citizens to adopt a healthy lifestyle in order to stop the growth of such diseases. In the aftermath of the COVID-19 pandemic, the healthcare costs have risen around the world and the trend is expected to continue in the future. “There are few areas in public health … where evidence on required action is so convincing, cost effective and practical,” the global report published by WHO stated. “A consequence of this ‘inaction’ is that already stretched health systems are burdened with preventable disease today and even more so in the future, and communities fail to benefit from the wider social, environmental and economic benefits associated with more people being more active.” Also read | Bomb blasts at Myanmar's Insein prison leave 8 dead, 18 injured While the advantages of exercise and physical activities are quite clear, the WHO noted that governments have not paid much attention to raising awareness. The situation is considerably worse in low-income countries where the standard of living is low and there is a lack of proper healthcare. Among the 194 countries included in the report, WHO found that less than 50 per cent have a clear national policy when it comes to healthy living, but it is not fully functional in all of those countries.

People's lack of exercise can cost global govts $27bn a year by 2030, WHO warns

The government-appointed committee investigating claims that four cough syrups made in India may have led&nbsp;to the deaths of 66 children in The Gambia has found that the clinical data provided by the WHO so far is insufficient to identify the aetiology.

Drugs Controller General of India (DCGI) V G Somani said that the WHO has been informed about this on Saturday.

On October 13, the WHO's Rutendo Kuwana wrote to the DCGI to inquire about the status of the inquiry into Maiden Pharmaceuticals, the Sonipat-based maker of the four cough syrups.

In response to an email, Dr&nbsp;Somani said on Saturday that the Union ministry of health has established a committee of technical specialists to review and analyse the specifics of the adverse event reports and any relevant information supplied or to be shared by WHO, and to recommend subsequent action.

Also read |&nbsp;<a href="https://www.wionews.com/india-news/india-kashmir-hosts-its-first-ever-international-bikers-expedition-525131">India: Kashmir hosts its first-ever international bikers’ expedition</a>

In its first meeting, the four-member committee, which is led by Dr Y. K. Gupta, Vice Chairperson of the Standing National Committee on Medicines, reviewed the reports and communications that have been so far received from the WHO. The committee also made a number of observations.

Mentioning the observations, Dr Somani said, "The clinical features and the treatment received by the children as shared by <a href="https://www.wionews.com/science/signs-of-dementia-can-be-detected-at-least-nine-years-prior-to-official-diagnosis-says-study-525111">WHO</a> so far are inadequate to determine the aetiology."

The specifics of the initial illness, <a href="https://www.wionews.com/science/scientists-have-successfully-implanted-and-integrated-human-brain-cells-into-newborn-rats-525434">signs</a> and symptoms, length of anura in the cases, results of laboratory tests including different markers and parameters, investigations for diethylene glycol and ethylene glycol on critical patient samples, treatment received prior to and following hospitalisation at the tertiary hospital in Gambia, treatment received prior to and following acute kidney injury was suspected, and reasons therefore, names and brands of the drugs,&nbsp;he said.

Dr Somani added that if a verbal autopsy was performed, the WHO might share a complete report.

Dr&nbsp;Somani has also enquired about the quantity of biological samples taken from children who had clinical symptoms similar to acute renal injury as well as the quantity of stool samples taken and analysed.

He also wanted information on the circumstances in which these items were used, as well as information on the product samples that were tested and found to be free of EG and DEG (as well as their composition).&nbsp;

"You are therefore requested to share the report on causal relations along with above details, as observed by the said Technical Committee at the earliest for further examination and follow up action at our level," he wrote.

"The manufacturing site has been inspected, test reports of sampled products from the laboratory are awaited and all the manufacturing activities of the manufacturer in question have been stopped," he said.

The four-person expert panel was set up by the Union health ministry on Wednesday to look into the specifics and adverse event reports regarding the deaths of 66 children in Gambia that may have been connected to four cough syrups produced by Maiden Pharmaceuticals' Sonipat facility. These reports were received from the WHO.

After reviewing and analysing the reports of adverse events, the causal relationship, and all relevant information that has already been shared by or will be shared by the World Health Organization, the committee will recommend a further course of action to the Drugs Controller General of India (DCGI).

WHO has not yet disclosed the connection between the deaths. To date, the WHO has provided CDSCO with the certificates of analysis, images, and summaries of each product sampled.

According to official sources, the WHO has announced that it is doing more inquiry.

While the Haryana State Drug Controller on October 7 issued Maiden Pharmaceuticals a show cause notice requesting an explanation of the "many contraventions" found during a recent inspection within a week or risk licence suspension or cancellation, the Haryana government on October 11 issued an order to cease all manufacturing operations of the company with immediate effect.

Official sources reported that the WHO has declared that it is doing additional inquiry.

(With inputs from agencies)

WATCH WION LIVE HERE:

<iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed" style="width:100%;max-width:560px;" width="560"></iframe>

The government-appointed committee investigating claims that four cough syrups made in India may have led to the deaths of 66 children in The Gambia has found that the clinical data provided by the WHO so far is insufficient to identify the aetiology.

The government-appointed committee investigating claims that four cough syrups made in India may have led to the deaths of 66 children in The Gambia has found that the clinical data provided by the WHO so far is insufficient to identify the aetiology. Drugs Controller General of India (DCGI) V G Somani said that the WHO has been informed about this on Saturday. On October 13, the WHO's Rutendo Kuwana wrote to the DCGI to inquire about the status of the inquiry into Maiden Pharmaceuticals, the Sonipat-based maker of the four cough syrups. In response to an email, Dr Somani said on Saturday that the Union ministry of health has established a committee of technical specialists to review and analyse the specifics of the adverse event reports and any relevant information supplied or to be shared by WHO, and to recommend subsequent action. Also read | India: Kashmir hosts its first-ever international bikers’ expedition In its first meeting, the four-member committee, which is led by Dr Y. K. Gupta, Vice Chairperson of the Standing National Committee on Medicines, reviewed the reports and communications that have been so far received from the WHO. The committee also made a number of observations. Mentioning the observations, Dr Somani said, "The clinical features and the treatment received by the children as shared by WHO so far are inadequate to determine the aetiology." The specifics of the initial illness, signs and symptoms, length of anura in the cases, results of laboratory tests including different markers and parameters, investigations for diethylene glycol and ethylene glycol on critical patient samples, treatment received prior to and following hospitalisation at the tertiary hospital in Gambia, treatment received prior to and following acute kidney injury was suspected, and reasons therefore, names and brands of the drugs, he said. Dr Somani added that if a verbal autopsy was performed, the WHO might share a complete report. Dr Somani has also enquired about the quantity of biological samples taken from children who had clinical symptoms similar to acute renal injury as well as the quantity of stool samples taken and analysed. He also wanted information on the circumstances in which these items were used, as well as information on the product samples that were tested and found to be free of EG and DEG (as well as their composition). "You are therefore requested to share the report on causal relations along with above details, as observed by the said Technical Committee at the earliest for further examination and follow up action at our level," he wrote. "The manufacturing site has been inspected, test reports of sampled products from the laboratory are awaited and all the manufacturing activities of the manufacturer in question have been stopped," he said. The four-person expert panel was set up by the Union health ministry on Wednesday to look into the specifics and adverse event reports regarding the deaths of 66 children in Gambia that may have been connected to four cough syrups produced by Maiden Pharmaceuticals' Sonipat facility. These reports were received from the WHO. After reviewing and analysing the reports of adverse events, the causal relationship, and all relevant information that has already been shared by or will be shared by the World Health Organization, the committee will recommend a further course of action to the Drugs Controller General of India (DCGI). WHO has not yet disclosed the connection between the deaths. To date, the WHO has provided CDSCO with the certificates of analysis, images, and summaries of each product sampled. According to official sources, the WHO has announced that it is doing more inquiry. While the Haryana State Drug Controller on October 7 issued Maiden Pharmaceuticals a show cause notice requesting an explanation of the "many contraventions" found during a recent inspection within a week or risk licence suspension or cancellation, the Haryana government on October 11 issued an order to cease all manufacturing operations of the company with immediate effect. Official sources reported that the WHO has declared that it is doing additional inquiry. (With inputs from agencies) WATCH WION LIVE HERE:

India committee tells WHO: Information on 'killer' cough syrups 'inadequate'

Authorities in India have halted production at Median Pharmaceuticals after the World Health Organization issued an advisory against this company's four cough syrups.

India: After WHO's alert, government's crackdown on Maiden pharma

World Health Organization director general&nbsp;Dr Tedros Adhanom Ghebreyesus&nbsp;indicated that long Covid is “devastating” the lives and livelihoods of tens of millions of people across the world. This includes wreaking havoc on the healthcare system, and economies not to mention affecting the day-to-day lives of the people living with the condition.&nbsp;

“Crushing fatigue. Brain fog making straightforward tasks almost impossible. Shortness of breath walking up the stairs,” are just some of many symptoms experienced by people living with long Covid (post-Covid-19 condition), said Tedros in a piece he wrote for the Guardian.&nbsp;

WHO first started recognising long Covid in mid-2020 after patient groups, researchers and clinicians that they work with found cases of prolonged Covid-19. The virus that first emerged in China in late 2019 and subsequently turned into a global pandemic&nbsp;killed at least 6.5 million people across the world and infected more than 600 million, said the report.&nbsp;

However, WHO estimates that 10% to 20% of survivors have been left with mid and long-term aforementioned symptoms of Covid-19. Additionally, women are nearly twice as likely as men to have contracted this condition, while “those hospitalised with severe Covid are more likely to develop the condition” said Tedros citing the data by WHO and the Institute for Health Metrics and Evaluation (IHME).&nbsp;

ALSO READ:&nbsp;<a href="https://www.wionews.com/science/women-are-significantly-more-likely-than-men-to-get-long-covid-study-490535">Women are significantly more likely than men to get long Covid: Study</a>

Since the data is mostly available from high-income countries, it does not portray a clear picture of how many people are actually suffering, said the WHO chief, however, they estimate that tens of millions of people, or perhaps more, have contracted long Covid. As of now, with no evidence of how to best treat the condition, many face “often lengthy” and “frustrating” waits for support or guidance, said Tedros.&nbsp;

This large number of people suffering also has dangerous implications for countries and economies still reeling from the multiple waves of Covid-19 cases, said the report. “While the pandemic has changed dramatically due to the introduction of many life saving tools, and there is light at the end of the tunnel, the impact of long Covid for all countries is very serious and needs immediate and sustained action equivalent to its scale,” said Tedros.&nbsp; 
 
The WHO chief has urged leaders to “seriously ramp up support” to minimise the suffering of those who have long Covid. “This plan should encompass, providing immediate access to antivirals to patients at high risk of serious disease, investing in research and sharing new tools and knowledge as they’re identified to prevent, detect and treat patients more effectively. It also means supporting patients physical and mental health as well as providing financial support for those who are unable to work,” said Tedros in the piece he wrote.&nbsp;

Therefore, to drive this effort forward the WHO chief mapped out a plan with five “key elements”:&nbsp;

1. Tedros addresses the importance of listening to “patient groups, researchers and health workers dealing with this condition which we are still learning about”, said the WHO chief. He added that governments should use this “first-hand knowledge” and adjust policies accordingly to diagnose, support and treat people. On the other hand, it is critical for health professionals to assure and communicate how long and frustrating the road to recovery can be but people do get better, said Tedros.&nbsp;

2. The second element includes ensuring equitable access to tests, therapeutics and vaccines in order to avoid infection and reduce the severity of Covid, indicated the WHO chief. He highlights that while 70% of people have been vaccinated, only 22% of people in low-income countries have received the vaccination.&nbsp;

ALSO READ:&nbsp;<a href="https://www.wionews.com/world/what-causes-covid-brain-fog-this-study-has-answer-may-help-devise-new-treatments-for-long-covid-495123">What causes Covid brain fog? This study has answer; may help devise new treatments for long Covid</a>

3. According to Tedros, there is also a need for systematic data collection on patients suffering from long Covid, since most of the data received by WHO is from high-income countries they are unaware of the impact on low and middle-income countries.&nbsp;

This gap in knowledge “undermines the overarching response and delays the scientific community from understanding the nature of long Covid and how best to treat it”, said the WHO chief urging countries to share their data with the organisation.&nbsp;

4. There is a large amount of research on long Covid for which Tedros has called for “sustained investment” which would help them expand their scientific understanding and develop better treatments and clinical management.&nbsp;

5. Lastly, he called for the integration of “multi-disciplinary care”, for people suffering from long Covid as they require a range of services, including “health and care workers with expertise in neurology, rehabilitation, psychology, speech therapy and respiratory therapy”, said the WHO chief. He reasoned that delayed clinical care can impact their quality of life as well as the length of time they suffer from the symptoms.&nbsp; 
&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

World Health Organization director general Dr Tedros Adhanom Ghebreyesus indicated that long Covid is “devastating” the lives and livelihoods of tens of millions of people across the world.

World Health Organization director general Dr Tedros Adhanom Ghebreyesus indicated that long Covid is “devastating” the lives and livelihoods of tens of millions of people across the world. This includes wreaking havoc on the healthcare system, and economies not to mention affecting the day-to-day lives of the people living with the condition. “Crushing fatigue. Brain fog making straightforward tasks almost impossible. Shortness of breath walking up the stairs,” are just some of many symptoms experienced by people living with long Covid (post-Covid-19 condition), said Tedros in a piece he wrote for the Guardian. WHO first started recognising long Covid in mid-2020 after patient groups, researchers and clinicians that they work with found cases of prolonged Covid-19. The virus that first emerged in China in late 2019 and subsequently turned into a global pandemic killed at least 6.5 million people across the world and infected more than 600 million, said the report. However, WHO estimates that 10% to 20% of survivors have been left with mid and long-term aforementioned symptoms of Covid-19. Additionally, women are nearly twice as likely as men to have contracted this condition, while “those hospitalised with severe Covid are more likely to develop the condition” said Tedros citing the data by WHO and the Institute for Health Metrics and Evaluation (IHME). ALSO READ: Women are significantly more likely than men to get long Covid: Study Since the data is mostly available from high-income countries, it does not portray a clear picture of how many people are actually suffering, said the WHO chief, however, they estimate that tens of millions of people, or perhaps more, have contracted long Covid. As of now, with no evidence of how to best treat the condition, many face “often lengthy” and “frustrating” waits for support or guidance, said Tedros. This large number of people suffering also has dangerous implications for countries and economies still reeling from the multiple waves of Covid-19 cases, said the report. “While the pandemic has changed dramatically due to the introduction of many life saving tools, and there is light at the end of the tunnel, the impact of long Covid for all countries is very serious and needs immediate and sustained action equivalent to its scale,” said Tedros. The WHO chief has urged leaders to “seriously ramp up support” to minimise the suffering of those who have long Covid. “This plan should encompass, providing immediate access to antivirals to patients at high risk of serious disease, investing in research and sharing new tools and knowledge as they’re identified to prevent, detect and treat patients more effectively. It also means supporting patients physical and mental health as well as providing financial support for those who are unable to work,” said Tedros in the piece he wrote. Therefore, to drive this effort forward the WHO chief mapped out a plan with five “key elements”: 1. Tedros addresses the importance of listening to “patient groups, researchers and health workers dealing with this condition which we are still learning about”, said the WHO chief. He added that governments should use this “first-hand knowledge” and adjust policies accordingly to diagnose, support and treat people. On the other hand, it is critical for health professionals to assure and communicate how long and frustrating the road to recovery can be but people do get better, said Tedros. 2. The second element includes ensuring equitable access to tests, therapeutics and vaccines in order to avoid infection and reduce the severity of Covid, indicated the WHO chief. He highlights that while 70% of people have been vaccinated, only 22% of people in low-income countries have received the vaccination. ALSO READ: What causes Covid brain fog? This study has answer; may help devise new treatments for long Covid 3. According to Tedros, there is also a need for systematic data collection on patients suffering from long Covid, since most of the data received by WHO is from high-income countries they are unaware of the impact on low and middle-income countries. This gap in knowledge “undermines the overarching response and delays the scientific community from understanding the nature of long Covid and how best to treat it”, said the WHO chief urging countries to share their data with the organisation. 4. There is a large amount of research on long Covid for which Tedros has called for “sustained investment” which would help them expand their scientific understanding and develop better treatments and clinical management. 5. Lastly, he called for the integration of “multi-disciplinary care”, for people suffering from long Covid as they require a range of services, including “health and care workers with expertise in neurology, rehabilitation, psychology, speech therapy and respiratory therapy”, said the WHO chief. He reasoned that delayed clinical care can impact their quality of life as well as the length of time they suffer from the symptoms. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

WHO chief warns about ‘devastating’ impact of long Covid on people, urges immediate action

World Mental Health Day is observed every year on October 10 across the world to raise awareness through various programmes and events in order to draw attention to mental health issues, while representing a global commitment to raise awareness around them to mobilise support.&nbsp;

World Mental Health Day 2022&nbsp;

This year’s theme is “Make mental health and well-being for all a global priority”. Several&nbsp;concerns have been raised by the World Health Organisation (WHO) which indicated that prior to the Covid-19 pandemic at least one in eight people worldwide were suffering from mental health issues. However, there was a lack of proper infrastructure to support mental health.&nbsp;

According to a WHO report, at least one in seven people from India suffers from mental illnesses like depression, anxiety and so on. Last year, World Mental Health Day was marked at the end of the ‘Mental Health Awareness Campaign Week’ by the Ministry of Health and Family Welfare in India.&nbsp;

The first World Mental Health Day was observed on October 10, 1992, as an annual activity by the World Federation for Mental Health (WFMH) a non-governmental organisation founded in 1948. Subsequently, in 1994, they started assigning particular themes for the annual event, seeing its popularity, “Improving the Quality of Mental Health Services throughout the World,” was the very first theme.&nbsp; 
 
ALSO READ: <a href="https://www.wionews.com/photos/world-mental-health-day-2021-5-bollywood-movies-about-mental-health-419643#dear-zindagi-419624">World Mental Health Day 2022: 5 Bollywood movies about mental health</a>

Status of mental health across the world&nbsp;

The report on the status of mental health across the world is based on the WHO data published earlier this year:&nbsp;

1. At least one in seven world’s adolescents suffer from mental health disorders.&nbsp; 
2. Depression is the most common mental health disorder, at least 5% of adults globally suffer from it, says WHO.&nbsp; 
3. More than 700,000 people die by suicide every year.&nbsp; 
4. Globally, suicide accounts for one in 100 deaths.&nbsp; 
5. People with severe mental disorders are likely to die at least 10 to 20 years earlier than the general population&nbsp; 
6. At least 40% of low-income countries do not include essential medicines like lithium carbonate mood stabilisers for bipolar disorder which have been on the WHO Model list for decades.&nbsp; 
7. Suicide is the fourth leading cause of death among 15-29-year-olds across the world.&nbsp; 
8. At least one in nine people in settings affected by conflict have a moderate or severe mental health disorder.&nbsp; 
9. WHO data shows that the Covid-19 pandemic has caused a 25% increase in cases of anxiety and depression.&nbsp;

Therefore, to have different events and programmes in line with World Mental Health Day whose primary goal is to raise awareness about mental health issues across the world.&nbsp; 
 
ALSO READ:&nbsp;<a href="https://www.wionews.com/world/un-calls-for-safeguarding-mental-health-on-the-job-lays-down-guidelines-to-tackle-stress-at-workplace-520462">UN calls for safeguarding mental health on the job, lays down guidelines to tackle stress at workplace</a>

According to the National Institute of Mental Health (NIMH), practising self-care can help you manage stress, increase energy and lower your risk of falling sick. Here are some of the ways recommended by the NIMH that you can practice self-care to improve both your physical and mental health:&nbsp;

1. Exercise regularly: According to NIMH, just 30 minutes of walking every day can help boost your mood and improve your health. Even small amounts of exercise can add up and do not be discouraged after just one time.&nbsp;

2. Eat healthy, regular meals and stay hydrated: A balanced diet and plenty of water can improve one's energy and focus throughout the day, this also includes limiting the intake of caffeinated beverages coffee and soft drinks.&nbsp;

3. Prioritising sleep: Make a schedule and stick to it to make sure you are getting enough sleep. This also includes limiting your exposure to blue light from screens and devices before bedtime as it can make it difficult to fall asleep.&nbsp;

4. Try relaxing activities: One can do this by exploring various relaxation or wellness programs or apps, which tend to incorporate meditation, muscle relaxation, or breathing exercises. This could also include journaling and other regular activities that can help you relax.&nbsp;

5. Setting goals and priorities: For this recommendation, the idea is to decide what must get done now and what can wait, including learning how to say “no” when the tasks start piling up and become overwhelming. Try to be mindful of what you have accomplished through the day as opposed to what you were unable to, says NIMH.&nbsp;

6. Stay connected: Reach out to family and friends who can help provide emotional support in times of difficulty.&nbsp;

7. Practising gratitude: This includes reminding yourself of daily things you are grateful for, be specific. One can also write it down or replay it in their mind.&nbsp;

These steps are not definite or work for everyone since everyone’s idea of self-care is different. It will take a lot of trial and error to discover and understand what works best for you. It is also “not a cure” for mental illnesses but understanding what causes or triggers your symptoms and how to best cope with them.&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

World Mental Health Day is observed every year on October 10 across the world to raise awareness through various programmes and events in order to draw attention to mental health issues, while representing a global commitment to raise awareness around them to mobilise support.

World Mental Health Day is observed every year on October 10 across the world to raise awareness through various programmes and events in order to draw attention to mental health issues, while representing a global commitment to raise awareness around them to mobilise support. World Mental Health Day 2022 This year’s theme is “Make mental health and well-being for all a global priority”. Several concerns have been raised by the World Health Organisation (WHO) which indicated that prior to the Covid-19 pandemic at least one in eight people worldwide were suffering from mental health issues. However, there was a lack of proper infrastructure to support mental health. According to a WHO report, at least one in seven people from India suffers from mental illnesses like depression, anxiety and so on. Last year, World Mental Health Day was marked at the end of the ‘Mental Health Awareness Campaign Week’ by the Ministry of Health and Family Welfare in India. The first World Mental Health Day was observed on October 10, 1992, as an annual activity by the World Federation for Mental Health (WFMH) a non-governmental organisation founded in 1948. Subsequently, in 1994, they started assigning particular themes for the annual event, seeing its popularity, “Improving the Quality of Mental Health Services throughout the World,” was the very first theme. ALSO READ: World Mental Health Day 2022: 5 Bollywood movies about mental health Status of mental health across the world The report on the status of mental health across the world is based on the WHO data published earlier this year: 1. At least one in seven world’s adolescents suffer from mental health disorders. 2. Depression is the most common mental health disorder, at least 5% of adults globally suffer from it, says WHO. 3. More than 700,000 people die by suicide every year. 4. Globally, suicide accounts for one in 100 deaths. 5. People with severe mental disorders are likely to die at least 10 to 20 years earlier than the general population 6. At least 40% of low-income countries do not include essential medicines like lithium carbonate mood stabilisers for bipolar disorder which have been on the WHO Model list for decades. 7. Suicide is the fourth leading cause of death among 15-29-year-olds across the world. 8. At least one in nine people in settings affected by conflict have a moderate or severe mental health disorder. 9. WHO data shows that the Covid-19 pandemic has caused a 25% increase in cases of anxiety and depression. Therefore, to have different events and programmes in line with World Mental Health Day whose primary goal is to raise awareness about mental health issues across the world. ALSO READ: UN calls for safeguarding mental health on the job, lays down guidelines to tackle stress at workplace According to the National Institute of Mental Health (NIMH), practising self-care can help you manage stress, increase energy and lower your risk of falling sick. Here are some of the ways recommended by the NIMH that you can practice self-care to improve both your physical and mental health: 1. Exercise regularly: According to NIMH, just 30 minutes of walking every day can help boost your mood and improve your health. Even small amounts of exercise can add up and do not be discouraged after just one time. 2. Eat healthy, regular meals and stay hydrated: A balanced diet and plenty of water can improve one's energy and focus throughout the day, this also includes limiting the intake of caffeinated beverages coffee and soft drinks. 3. Prioritising sleep: Make a schedule and stick to it to make sure you are getting enough sleep. This also includes limiting your exposure to blue light from screens and devices before bedtime as it can make it difficult to fall asleep. 4. Try relaxing activities: One can do this by exploring various relaxation or wellness programs or apps, which tend to incorporate meditation, muscle relaxation, or breathing exercises. This could also include journaling and other regular activities that can help you relax. 5. Setting goals and priorities: For this recommendation, the idea is to decide what must get done now and what can wait, including learning how to say “no” when the tasks start piling up and become overwhelming. Try to be mindful of what you have accomplished through the day as opposed to what you were unable to, says NIMH. 6. Stay connected: Reach out to family and friends who can help provide emotional support in times of difficulty. 7. Practising gratitude: This includes reminding yourself of daily things you are grateful for, be specific. One can also write it down or replay it in their mind. These steps are not definite or work for everyone since everyone’s idea of self-care is different. It will take a lot of trial and error to discover and understand what works best for you. It is also “not a cure” for mental illnesses but understanding what causes or triggers your symptoms and how to best cope with them. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

World Mental Health Day 2022: Status of mental health across the world

Police in Gambia on Saturday announced they were launching an investigation into the deaths of dozens of children, amid growing concern over imported medicines.&nbsp;Following the deaths of 66 children, most from acute kidney failure, police said in a statement they were putting senior officers on the investigation.

India is investigating cough syrups made by a local pharmaceutical company after the World Health Organisation said they could be responsible for the deaths.

Watch |&nbsp;Gravitas: Gambia Cough Syrup deaths: All you need to know

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-gambia-cough-syrup-deaths-all-you-need-to-know-523133/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

President Adama Barrow authorised the health authorities "to suspend the license of the suspected... importer" involved in the case, his office said on Saturday evening.&nbsp;

The foreign ministry was to communicate "his government's most profound concern" to the Indian embassy, it added.

Barrow on Friday promised to boost health measures including better quality control over imported medicines.

Also read |&nbsp;<a href="https://www.wionews.com/india-news/cough-syrup-case-who-yet-to-provide-exact-one-to-one-casual-relation-of-deaths-in-gambia-522919">Gambia cough syrup row:&nbsp;Indian body says WHO yet to provide 'one to one causal relation of deaths'</a>

He said the government would leave "no stone unturned" to get to the bottom of the incident.

The WHO on Wednesday issued an alert over four cough and cold syrups made by Maiden Pharmaceuticals in India over possible links to the deaths.

Laboratory testing had found unacceptable levels of potentially life-threatening contaminants, the WHO said, adding that the products may have been distributed beyond the West African country.

Also read |&nbsp;​​​​​​​<a href="https://www.wionews.com/world/who-alleges-made-in-india-cough-syrup-linked-to-death-of-66-kids-in-gambia-probe-underway-522809">WHO alleges 'made in India' cough syrup linked to death of 66 kids in Gambia, probe underway</a>

Gambian health authorities had on September 23 ordered a recall of all medicines containing paracetamol or promethazine syrup.

Barrow announced a raft of measures to avoid future tragedies, including the creation of "a quality control national laboratory for drugs and food safety".

He also promised to update the nation's drugs-related laws to ensure regulation could prevent any such incidents in the future.&nbsp;He praised the work of the health ministry in preventing further deaths.&nbsp;He said the outbreak was "now under control, with only two cases reported in the last two weeks".

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Police in Gambia on Saturday announced they were launching an investigation into the deaths of dozens of children, amid growing concern over imported medicines. Following the deaths of 66 children, most from acute kidney failure, police said in a statement they were putting senior officers on the investigation.

Police in Gambia on Saturday announced they were launching an investigation into the deaths of dozens of children, amid growing concern over imported medicines. Following the deaths of 66 children, most from acute kidney failure, police said in a statement they were putting senior officers on the investigation. India is investigating cough syrups made by a local pharmaceutical company after the World Health Organisation said they could be responsible for the deaths. Watch | Gravitas: Gambia Cough Syrup deaths: All you need to know President Adama Barrow authorised the health authorities "to suspend the license of the suspected... importer" involved in the case, his office said on Saturday evening. The foreign ministry was to communicate "his government's most profound concern" to the Indian embassy, it added. Barrow on Friday promised to boost health measures including better quality control over imported medicines. Also read | Gambia cough syrup row: Indian body says WHO yet to provide 'one to one causal relation of deaths' He said the government would leave "no stone unturned" to get to the bottom of the incident. The WHO on Wednesday issued an alert over four cough and cold syrups made by Maiden Pharmaceuticals in India over possible links to the deaths. Laboratory testing had found unacceptable levels of potentially life-threatening contaminants, the WHO said, adding that the products may have been distributed beyond the West African country. Also read | WHO alleges 'made in India' cough syrup linked to death of 66 kids in Gambia, probe underway Gambian health authorities had on September 23 ordered a recall of all medicines containing paracetamol or promethazine syrup. Barrow announced a raft of measures to avoid future tragedies, including the creation of "a quality control national laboratory for drugs and food safety". He also promised to update the nation's drugs-related laws to ensure regulation could prevent any such incidents in the future. He praised the work of the health ministry in preventing further deaths. He said the outbreak was "now under control, with only two cases reported in the last two weeks". WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Gambia police launch enquiry into cough syrup related deaths, President says outbreak 'now under control'

The World Health Organization (WHO) is yet to provide the exact "one to one causal&nbsp;relation of deaths," said sources at the Indian drugs standards body after the UN agency linked deaths of 66 children in Gambia to India-made cough syrups, media reports said.&nbsp;

"While all required steps will be taken, as a robust regulatory authority, WHO has been requested to share with CDSCO at the earliest the report on the establishment of a causal relation to the deaths with the medical products in question, photographs of labels/products, etc," PTI quoted an official source as saying.&nbsp;CDSCO stands for the Central Drugs Standard Control Organisation.

<a href="https://www.wionews.com/india-news/india-registers-decline-in-female-infant-mortality-rate-smriti-irani-522839">Also read |&nbsp;India registers decline in female infant mortality rate: Minister Smriti Irani</a>

The WHO had issued a warning on Wednesday (October 6) against allegedly "contaminated" cough syrups manufactured in Haryana by Maiden Pharmaceuticals Limited as a possible cause of deaths in the West African nation.

The WHO earlier informed the Drugs Controller General of India that it is providing medical assistance to Gambia. After the deaths were reported, the health organisation suspected the use of medicines to be the prime reason for the deaths. It highlighted that medicines might have been contaminated with diethylene glycol or ethylene glycol and later confirmed the samples to be positive as well.&nbsp;

As per WHO's tentative result, four out of the 23 samples found diethylene glycol or ethylene glycol.

The CDSCO said that it responded to the WHO immediately and took up the matter with the authorities.&nbsp;

<a href="https://www.wionews.com/world/who-alleges-made-in-india-cough-syrup-linked-to-death-of-66-kids-in-gambia-probe-underway-522809">Also read |&nbsp;WHO alleges 'made in India' cough syrup linked to death of 66 kids in Gambia, probe underway</a>

The source further added that a detailed investigation was launched into the matter with the Haryana State Drugs Controller.&nbsp;

WHO has also confirmed that soon India will share the certificate of analysis.

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

The World Health Organization (WHO) is yet to provide the exact "one to one causal relation of deaths," said sources at the Indian drugs standards body after the UN agency linked deaths of 66 children in Gambia to India-made cough syrups, media reports said.

The World Health Organization (WHO) is yet to provide the exact "one to one causal relation of deaths," said sources at the Indian drugs standards body after the UN agency linked deaths of 66 children in Gambia to India-made cough syrups, media reports said. "While all required steps will be taken, as a robust regulatory authority, WHO has been requested to share with CDSCO at the earliest the report on the establishment of a causal relation to the deaths with the medical products in question, photographs of labels/products, etc," PTI quoted an official source as saying. CDSCO stands for the Central Drugs Standard Control Organisation. Also read | India registers decline in female infant mortality rate: Minister Smriti Irani The WHO had issued a warning on Wednesday (October 6) against allegedly "contaminated" cough syrups manufactured in Haryana by Maiden Pharmaceuticals Limited as a possible cause of deaths in the West African nation. The WHO earlier informed the Drugs Controller General of India that it is providing medical assistance to Gambia. After the deaths were reported, the health organisation suspected the use of medicines to be the prime reason for the deaths. It highlighted that medicines might have been contaminated with diethylene glycol or ethylene glycol and later confirmed the samples to be positive as well. As per WHO's tentative result, four out of the 23 samples found diethylene glycol or ethylene glycol. The CDSCO said that it responded to the WHO immediately and took up the matter with the authorities. Also read | WHO alleges 'made in India' cough syrup linked to death of 66 kids in Gambia, probe underway The source further added that a detailed investigation was launched into the matter with the Haryana State Drugs Controller. WHO has also confirmed that soon India will share the certificate of analysis. (With inputs from agencies) WATCH WION LIVE HERE

Gambia cough syrup row: Indian body says WHO yet to provide 'one to one causal relation of deaths'

The World Health Organisation has issued an alert against four India-made cold and cough syrups that have been "potentially linked" with acute kidney injuries and 66 deaths among children in the African country Gambia.

WHO labels four cough syrups as 'substandard products; Indian pharmaceutical company in the dock?

Who, News on Who, stories on Who, articles on Who, Who stories at Wion, Who news, Who latest news